Abstract
Effect of a aingle i.v. infusion of zoledronic acid on bone turnover markers versus oral risedronate in patients with glucocorticoidinduced osteoporosis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have